SM
CBAY

Sabby Management’s Cymabay Therapeutics CBAY Stock Holding History

Sabby Management’s Portfolio CBAY Stock Details CBAY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-67,534
Closed -$91K – 342
2016
Q1 		$91K Sell
67,534
-526,366
-89% -$652K ﹤0.01% 276
2015
Q4 		$1M Buy
593,900
+300,606
+102% +$490K 0.06% 182
2015
Q3 		$569K Buy
293,294
+193,294
+193% +$526K 0.02% 281
2015
Q2 		$269K Hold
100,000
– – 0.01% 287
2015
Q1 		$692K Sell
100,000
-800
-0.8% -$7.68K 0.03% 215
2014
Q4 		$991 Sell
100,800
-149,100
-60% -$1.2M 0.03% 159
2014
Q3 		$1.71K Buy
+249,900
New +$1.54M 0.07% 124

Other funds holding CBAY

A
Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $957M AUM 35.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sabby Management's CBAY Position: Q2 2016 in Review

Sabby Management sold out of Cymabay Therapeutics (CBAY) in Q2 2016, closing a stake of 67,534 shares — an estimated $91K sold.

Sabby Management first reported a position in CBAY in Q3 2014 and held it in 7 quarters. The position peaked at $1M in Q4 2015. 26 funds tracked by Wall St. Rank hold CBAY as of Q2 2016.

  • Sabby Management reported no remaining Cymabay Therapeutics position as of Q2 2016 after selling out during the quarter.
  • Sabby Management sold 67,534 Cymabay Therapeutics shares in Q2 2016, an estimated $91K.
  • Sabby Management first reported a position in Cymabay Therapeutics in Q3 2014 and held it in 7 quarters.
  • Sabby Management's Cymabay Therapeutics position peaked at $1M in Q4 2015.
  • 26 funds tracked by Wall St. Rank held Cymabay Therapeutics as of Q2 2016.

Based on Sabby Management's 13F filing for Q2 2016, filed 15 Aug 2016.